SARS-CoV-2 ORF7a Antikörper (AA 16-111)
Kurzübersicht für SARS-CoV-2 ORF7a Antikörper (AA 16-111) (ABIN7469591)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 16-111
-
Kreuzreaktivität
- SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
-
Aufreinigung
- Affinity purified by Protein G.
-
Immunogen
- The immunogen used to generate this antibody corresponds to SARS-CoV ORF7a protein (16-111 a.a.).
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Kommentare
-
Positive Control: ORF7a-transfected 293T cell
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, No Preservative
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- SARS-CoV-2 ORF7a
-
Hintergrund
- 2019-nCoV ORF7a , SARS-coV-2 ORF7a , COVID-19 ORF7a
Target
-